表紙
市場調查報告書

亞太地區的自我監測血糖儀(SMBG)市場 - 成長,趨勢,預測(2019年∼2024年)

Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 808268
出版日期 內容資訊 英文 95 Pages
商品交期: 2-3個工作天內
價格
亞太地區的自我監測血糖儀(SMBG)市場 - 成長,趨勢,預測(2019年∼2024年) Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 95 Pages
簡介

亞太地區的自我監測血糖儀(SMBG)依然處於成長階段。中國的自我監測血糖儀市場,預測2019年將達到9億美元規模。由於糖尿病患者數的增加,及診斷及治療藥的持續性創新促進該市場成長。

本報告提供亞太地區的自我監測血糖儀(SMBG)市場調查,市場概要,各各類別的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 血糖自我監測測量儀
    • 各零件
      • 血糖儀
      • 測試紙
      • 採血針
    • 各終端用戶
      • 醫院
      • 個人
  • 各地區
    • 亞太地區
      • 日本
      • 韓國
      • 中國
      • 印度
      • 澳洲
      • 越南
      • 馬來西亞
      • 印尼
      • 菲律賓
      • 泰國
      • 其他

第6章 市場指標

  • 第一型糖尿病人口(實在數值、預測值)
  • 第二型糖尿病人口(實在數值、預測值)

第7章 競爭情形

  • 企業簡介
    • Abbott Diabetes Care
    • Roche
    • Johnson & Johnson
    • Arkray
    • Ascensia Diabetes Care
    • Agamatrix Inc.
    • Bionime Corporation
    • Acon
    • Medisana
    • Trivida
    • I-Sens
    • Morpen Laboratories
    • Rossmax
  • 企業佔有率分析
    • Roche
    • Johnson & Johnson
    • Abbott Diabetes Care
    • 其他

第8章 市場機會及市場趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 65537

The Asia-Pacific self-monitoring blood glucose devices market is segmented into blood glucose meters, blood glucose testing strips, and lancets. Self-monitoring blood glucose (SMBG) devices markets across the Asia Pacific are still in their growing phases. Approximately 10% of the diabetes population, in the Asia Pacific region, are type-1 diabetic and 90% are type-2 diabetes patients. Type-1 patients need to take insulin throughout their life, along with maintaining a healthy diet and regular physical exercise. Type-2 patients need to eat healthily, be physically active, and take a regular test to check their blood glucose level. They may also need to take oral medication and insulin to control the glucose levels in the blood. Diabetes, as a condition, has many complications associated with it, including diabetic ketoacidosis and non-ketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers, and damage to the eyes. To avoid these complications, the patients need to regularly monitor their blood glucose levels to keep their glucose levels in control and hence, patients check their blood glucose levels with the help of glucometers and test strips.

Scope of the Report

The market is segmented by component (Glucometer device, Test Strips and Lancets), by end-user (hospital use and personal use) and by geography.

Key Market Trends

In Asia-Pacific, Glucometer Device Segment Registered the Highest CAGR with 7.23%

The Glucometer Devices market is expected to see high sales in the future, owing to the rising awareness and innovations associated with the glucometer. The technologies in glucometer devices are leading the glucometer devices market. Glucometer companies designing smart glucometer devices that are now connected to mobile devices help diabetes patients, their, parents, or friends know their health condition in critical times immediately. Even the companies with mobile apps like, Roche's Mysugar logbook app, and the companies that don't have their mobile app are trying to manufacture glucometers such that they go with all the diabetes mobile applications. The Arcadia Group designed smart glucometer devices that are connected to mobile devices created by Aggamatrix. For this, both the companies, Aggamatrix and Arcadia, got into an agreement.

China has the Highest Market Share in Asia-Pacific and Will Continue to Grow in the Future with the CAGR of 7.48%

In China, about 123 million patients were suffering from diabetes mellitus in 2019, with a prevalence rate of 11.2% among adults. Of the 123 million diabetic patients, 12.18 million were type-1 patients and 111.42 million were type-2 patients. These numbers are expected to increase during the forecast period. China holds the highest market share in the Asia-Pacific glucometer devices market. In China, due to the lifestyle and food habits, blood glucose fluctuations among insulin users are frequent from time to time. China is a mature market with the associated challenges of slow economic growth and ageing population. In 2019, in the Chinese blood glucose monitoring devices market, the consumables accounted for 87.5%, of which, 85.68% of the market share was held by test strips and the 14.3% was occupied by lancets.

Competitive Landscape

The Asia-Pacific self-monitoring blood glucose devices market is highly fragmented with few major manufacturers gaining presence in major countries of the Asia-Pacific market, while the remaining market comprises other local or region-specific manufacturers. Mergers and acquisitions that happened between players in the recent past helped the companies to strengthen their market presence; for instance, In South Korea, Arkray started the Development Center in Gunpo, in 2018 to develop new systems for Arkray's main business of manufacturing self-monitoring blood glucose meters, test strips, and lancets.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Self -monitoring Blood Glucose Devices
    • 5.1.1 By Component (Market Size, Value and Volume)
      • 5.1.1.1 Glucometer Devices
      • 5.1.1.2 Test Strips
      • 5.1.1.3 Lancets
    • 5.1.2 By End User
      • 5.1.2.1 Hospital (Market Size, Value and Volume)
      • 5.1.2.1.1 Glucometer Devices
      • 5.1.2.1.2 Test Strips
      • 5.1.2.1.3 Lancets
      • 5.1.2.2 Personal (Market Size, Value and Volume)
      • 5.1.2.2.1 Glucometer Devices
      • 5.1.2.2.2 Test Strips
      • 5.1.2.2.3 Lancets
  • 5.2 By Geography
    • 5.2.1 Asia-Pacific
      • 5.2.1.1 Japan (Market Size, Value and Volume)
      • 5.2.1.1.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.1.2 By End User (Hospital and Home)
      • 5.2.1.2 South Korea (Market Size, Value and Volume)
      • 5.2.1.2.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.2.2 By End User (Hospital and Home)
      • 5.2.1.3 China (Market Size, Value and Volume)
      • 5.2.1.3.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.3.2 By End User (Hospital and Home)
      • 5.2.1.4 India (Market Size, Value and Volume)
      • 5.2.1.4.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.4.2 By End User (Hospital and Home)
      • 5.2.1.5 Australia (Market Size, Value and Volume)
      • 5.2.1.5.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.5.2 By End User (Hospital and Home)
      • 5.2.1.6 Vietnam (Market Size, Value and Volume)
      • 5.2.1.6.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.6.2 By End User (Hospital and Home)
      • 5.2.1.7 Malaysia (Market Size, Value and Volume)
      • 5.2.1.7.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.7.2 By End User (Hospital and Home)
      • 5.2.1.8 Indonesia (Market Size, Value and Volume)
      • 5.2.1.8.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.8.2 By End User (Hospital and Home)
      • 5.2.1.9 Philippines (Market Size, Value and Volume)
      • 5.2.1.9.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.9.2 By End User (Hospital and Home)
      • 5.2.1.10 Thailand (Market Size, Value and Volume)
      • 5.2.1.10.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.10.2 By End User (Hospital and Home)
      • 5.2.1.11 Rest of Asia-Pacific (Market Size, Value and Volume)
      • 5.2.1.11.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.11.2 By End User (Hospital and Home)

6 MARKET INDICATORS

  • 6.1 Type 1 Diabetes Population (2012-2025)
  • 6.2 Type 2 Diabetes Population (2012-2025)

7 COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche
    • 7.1.3 Johnson & Johnson
    • 7.1.4 Arkray
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 I-Sens
    • 7.1.12 Morpen Laboratories
    • 7.1.13 Rossmax

8 MARKET OPPORTUNITIES AND FUTURE TRENDS